glp 1 naion π Optometrists are warning GLP-1 drugs may pose these types of rare risks π β¬οΈ Details in comments Glucagon-like Peptide-1 Receptor Agonists and
Description
Reverse damage

A., Willingham, B., Kephart, W., Mobley, C

30, Sept

One of these was GIP which Turner took back to Surrey University where he had moved to from the Royal Free Hospital

has received consulting fees from Amgen, Eli Lilly and Esperion and speaker honoraria from Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Merck Schering-Plough, Novartis, Novo Nordisk, Pfizer and Sanofi
